News
🇺🇸 FDA Page 63Latest pharmaceutical news, drug approvals, and FDA regulatory updates
Showing 745–756 of 807 articles
FDA Approves Higher-Dose Wegovy 7.2mg for Weight Loss Under Priority Review Program
FDA · obesity/weight management · 3 min
Dr. Sarah MitchellFDA Approves First Treatment for Neurologic Symptoms of Hunter Syndrome
FDA · 2 min
Dr. Sarah MitchellFDA Approves Kresladi: First Gene Therapy for Rare Immune Disorder LAD-I Marks Medical Breakthrough
FDA · Rare genetic immunodeficiency disorders · 3 min
Dr. Sarah MitchellFDA Approves Foundayo's Orforglipron as First New Molecular Entity Under Priority Voucher Program
FDA · 2 min
Dr. Sarah MitchellFDA Approves SkinGuard: New Topical Treatment for Severe Eczema
FDA · Severe Eczema · 6 min
Prof. Marcus WebbFDA Approves CogniMax: New Early-Stage Alzheimer's Treatment
FDA · Alzheimer's disease · 7 min
Dr. Sarah MitchellFDA Approves VitaRestore: New Treatment for Age-Related Macular Degeneration
FDA · Age-Related Macular Degeneration · 6 min
Dr. Sarah MitchellFDA Approves NasoClear: First Nasal Spray for Pediatric RSV
FDA · Pediatric Infectious Diseases · 6 min
Dr. Sarah MitchellFDA Approves Revitalize: Breakthrough for Chronic Fatigue Syndrome
FDA · Chronic Fatigue Syndrome · 6 min
Dr. Sarah MitchellFDA Approves GeneCorrect: GeneTech's Breakthrough Cystic Fibrosis Therapy
FDA · Cystic Fibrosis · 7 min
Dr. Sarah MitchellFDA Approves MyoRepair: Breakthrough Therapy for Heart Failure
FDA · Heart Failure · 7 min
Dr. Sarah MitchellFDA Approval OncoBlock: Accelerated Approval for Refractory AML
FDA · Acute Myeloid Leukemia · 6 min
Dr. Sarah MitchellPopular topics
- Drug Approvals 1,128 articles
- Clinical Trials 634 articles
- Regulatory Updates 687 articles
- FDA News 502 articles
- Press Releases 443 articles
- Oncology 443 articles
- Rare Diseases 141 articles
Explore intelligence
- Global markets Cross-region command center
- Company directory Sponsor & marketer profiles
- Drug profiles INN & regulatory status
- Clinical trials hub Stage & therapy filters
- Pipeline programs R&D intelligence
- Patent landscape US & EP IP moats
- Event calendar Congress catalysts
- Regulatory reference Submission types & pathways